C4 Therapeutics, Inc.
CCCC · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 6, 2026 | — | 8.20M | — | -0.23 | — |
| 2026 Q1 | May 12, 2026 | 6.15M | 4.42M | -0.20 | -0.21 | -1.36% |
| 2025 Q4 | February 26, 2026 | 11.02M | 5.39M | -0.18 | -0.43 | -2.88% |
| 2025 Q3 | November 6, 2025 | 11.20M | 6.28M | -0.44 | -0.47 | -1.68% |
| 2025 Q2 | August 7, 2025 | 6.46M | 6.55M | -0.37 | -0.38 | -3.10% |
| 2025 Q1 | May 7, 2025 | 7.20M | 4.45M | -0.37 | -0.48 | — |
| 2024 Q4 | February 27, 2025 | 5.18M | 5.09M | -0.49 | -0.44 | +4.23% |
| 2024 Q3 | October 31, 2024 | 15.40M | 5.90M | -0.35 | -0.40 | — |
| 2024 Q2 | August 1, 2024 | 12.01M | 4.78M | -0.26 | -0.37 | — |
| 2024 Q1 | May 8, 2024 | 3.04M | 11.99M | -0.41 | -0.41 | -9.41% |
| 2023 Q4 | February 22, 2024 | 3.27M | 3.20M | -0.68 | -0.67 | +2.16% |
| 2023 Q3 | November 1, 2023 | 11.07M | 5.28M | -0.55 | -0.65 | +11.43% |
| 2023 Q2 | August 8, 2023 | 2.66M | 6.41M | -0.73 | -0.74 | -0.58% |
| 2023 Q1 | May 4, 2023 | 3.76M | 5.46M | -0.71 | -0.78 | +1.86% |
| 2022 Q4 | February 23, 2023 | 2.85M | 9.87M | -0.76 | -0.72 | -11.46% |
| 2022 Q3 | November 3, 2022 | 6.75M | 8.45M | -0.65 | -0.67 | — |